Your browser doesn't support javascript.
loading
Pharmaceutical and in vitro therapeutic equivalence studies of ketoprofen enteric coated 100 mg tablets
Pakistan Journal of Pharmaceutical Sciences. 2017; 30 (1): 179-186
in English | IMEMR | ID: emr-185756
ABSTRACT
The objective of this study was to assess the quality of six different brands of enteric coated Ketoprofen 100 mg tablets, KPB[2] to KPB[6] are available in commercial market of Karachi, Pakistan, while KPB[1] was obtained from international source. We performed different physico-chemical assessments i.e. weight variation, diameter, hardness, friability, thickness, disintegration, content uniformity, assay and dissolution test. Results of all the investigations were found to be in adequate limits. Also pharmaceutical equivalence was determined by selecting different tests and assay assessment. Furthermore, in vitro therapeutic equivalence was also estimated at phosphate buffer pH 6.8 and 7.5. Results were evaluated by one way ANOVA, model independent and model dependent methods. ANOVA results showed that release behaviour were found to be similar as p values >0.05, also KPB[1] - KPB[6] followed Weibull model at different dissolution media. Results indicated that innovator and brands not only passes the pharmaceutical equivalence assessment but also comply with the in vitro therapeutic equivalence
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Pakistan / Quality Control / Tablets, Enteric-Coated / Anti-Inflammatory Agents, Non-Steroidal / Drug Compounding / Models, Chemical Country/Region as subject: Asia Language: English Journal: Pak. J. Pharm. Sci. Year: 2017

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Pakistan / Quality Control / Tablets, Enteric-Coated / Anti-Inflammatory Agents, Non-Steroidal / Drug Compounding / Models, Chemical Country/Region as subject: Asia Language: English Journal: Pak. J. Pharm. Sci. Year: 2017